Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 2
2006 2
2007 2
2008 6
2009 7
2010 4
2011 6
2012 3
2013 6
2014 7
2015 3
2016 4
2017 7
2018 3
2019 5
2020 1
2022 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.
Jørgensen KK, Olsen IC, Goll GL, Lorentzen M, Bolstad N, Haavardsholm EA, Lundin KEA, Mørk C, Jahnsen J, Kvien TK; NOR-SWITCH study group. Jørgensen KK, et al. Lancet. 2017 Jun 10;389(10086):2304-2316. doi: 10.1016/S0140-6736(17)30068-5. Epub 2017 May 11. Lancet. 2017. PMID: 28502609 Clinical Trial.
Cohort profile: Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
Søgaard AJ, Meyer HE, Emaus N, Grimnes G, Gjesdal CG, Forsmo S, Schei B, Tell GS. Søgaard AJ, et al. Among authors: gjesdal cg. Scand J Public Health. 2014 Dec;42(8):804-13. doi: 10.1177/1403494814551858. Epub 2014 Oct 2. Scand J Public Health. 2014. PMID: 25278275
Urban-Rural Differences in Hip Fracture Mortality: A Nationwide NOREPOS Study.
Solbakken SM, Magnus JH, Meyer HE, Dahl C, Stigum H, Søgaard AJ, Holvik K, Tell GS, Emaus N, Forsmo S, Gjesdal CG, Schei B, Vestergaard P, Omsland TK. Solbakken SM, et al. Among authors: gjesdal cg. JBMR Plus. 2019 Oct 21;3(11):e10236. doi: 10.1002/jbm4.10236. eCollection 2019 Nov. JBMR Plus. 2019. PMID: 31768493 Free PMC article.
Ten-year risk of second hip fracture. A NOREPOS study.
Omsland TK, Emaus N, Tell GS, Ahmed LA, Center JR, Nguyen ND, Gjesdal CG, Forsmo S, Schei B, Søgaard AJ, Meyer HE. Omsland TK, et al. Among authors: gjesdal cg. Bone. 2013 Jan;52(1):493-7. doi: 10.1016/j.bone.2012.09.009. Epub 2012 Sep 18. Bone. 2013. PMID: 23000506
Continued decline in hip fracture incidence in Norway: a NOREPOS study.
Søgaard AJ, Holvik K, Meyer HE, Tell GS, Gjesdal CG, Emaus N, Grimnes G, Schei B, Forsmo S, Omsland TK. Søgaard AJ, et al. Among authors: gjesdal cg. Osteoporos Int. 2016 Jul;27(7):2217-2222. doi: 10.1007/s00198-016-3516-8. Epub 2016 Feb 22. Osteoporos Int. 2016. PMID: 26902091
62 results